TP53 and breast cancer (Q35078761)

6 August 2017

1 reference

title

TP53 and breast cancer (English)

1 reference

6 August 2017

1 reference

Anne-Lise Børresen-Dale

series ordinal

object named as

Anne-Lise Børresen-Dale

1 reference

6 August 2017

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

292-300

1 reference

The UMD-p53 database: new mutations and analysis tools

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

TP53 mutations in familial breast cancer: functional aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

The molecular epidemiology of p53 gene mutations in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

p53 as a mutagen test in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

The IARC TP53 database: new online mutation analysis and recommendations to users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

TP53 mutations in breast cancer tumors of patients from Rio de Janeiro, Brazil: association with risk factors and tumor characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

Assessing TP53 status in human tumours to evaluate clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

The TP53 gene, tobacco exposure, and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

TP53 mutations in workers exposed to occupational carcinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li – Fraumeni patients carrying a mutation to the TP53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

Prognostic significance of TP53 alterations in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

p53 gene mutation: software and database

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysis

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

In microdissected ductal carcinoma in situ, HER-2/neu amplification, but notp53 mutation, is associated with high nuclear grade and comedo histology

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

Poor prognosis of p53 gene mutation and nuclear overexpression of p53 protein in inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

p53 Website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10174

7 January 2021

Identifiers

DOI

10.1002/HUMU.10174

1 reference

6 August 2017

1 reference